article thumbnail

A Thorny PMA Preemption Decision from Rhode Island

Drug & Device Law

Plaintiff countered that she and her doctors took many steps to try to identify the source of her symptoms, but that defendants’ failure to report the higher migration rates prevented them from exploring that as a cause.

FDA 52